Örebro University Hospital
Welcome,         Profile    Billing    Logout  
 72 Trials 
132 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nilsson, Olof
NCT04398121: NBI in Oral Cavity Cancer

Completed
N/A
49
Europe
Region Örebro County
Oral Cancer
03/24
03/24
LEVIN, Mark-David
NCT03868722: Acalabrutinib and Venetoclax Treatment of Newly Diagnosed Patients With CLL at High Risk of Infection or Early Treatment

Recruiting
2/3
212
Europe
Acalabrutinib, Calquence, Venetoclax, Venclexta, Venclyxto
Rigshospitalet, Denmark, Stichting Hemato-Oncologie voor Volwassenen Nederland, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Karolinska Institutet
CLL
07/29
07/30
DREAMM 5, NCT04126200 / 2019-001138-32: Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

Hourglass Jul 2021 - Dec 2021 : From DREAMM-5 trial in combination with nirogacestat for r/r multiple myeloma
Hourglass Feb 2020 - Mar 2020 : Initiation of P1b sub-study of P2 DREAMM-5 trial in combination with nirogacestat for relapsed/refractory multiple myeloma
Checkmark From DREAMM 5 trial in R/R multiple myeloma patients at ASH 2019
Nov 2019 - Nov 2019: From DREAMM 5 trial in R/R multiple myeloma patients at ASH 2019
Checkmark Initiation of DREAMM-5 trial in r/r multiple myeloma
More
Recruiting
1/2
464
Europe, Canada, Japan, US, RoW
Belantamab mafodotin, GSK3174998, Feladilimab, Nirogacestat, Dostarlimab, Isatuximab, Lenalidomide, Dexamethasone, Pomalidomide
GlaxoSmithKline
Multiple Myeloma
02/26
02/29
IONA-MM, NCT04458831: A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)

Recruiting
N/A
1200
Europe, Japan, US, RoW
isatuximab SAR650984, Sarclisa, Pomalidomide, Pomalyst, Dexamethasone, Carfilzomib
Sanofi
Plasma Cell Myeloma
02/26
02/26
Bobinski, Lukas
SunBurst, NCT05003180: StUdy oN Burst Fractures

Recruiting
N/A
202
Europe
Surgical stabilization
Uppsala University, Sahlgrenska University Hospital, Sweden, Uppsala University Hospital, University Hospital, Umeå, University Hospital, Linkoeping, Skane University Hospital, Region Örebro County, Stockholm South General Hospital, Karolinska University Hospital, Oslo University Hospital, Haukeland University Hospital, Helse Stavanger HF, University Hospital, Akershus, Kalmar County Hospital, Ryhov County Hospital, Halmstad County Hospital, Centrallasarettet Västerås, St. Olavs Hospital, Karolinska Institutet
Thoracolumbar Burst Fracture
12/25
12/36
OMSAP, NCT04177849: Örebro Multicenter Study on Operative Treatment of Cervical Radiculopathy

Recruiting
N/A
110
Europe
ACDF, PF
Region Örebro County, Uppsala University Hospital, Rygglkirurgiskt Centrum Stockholm AB, Norrlands University Hospital
Cervical Radiculopathy, Cervical Root Compression
01/26
01/26
Valachis, Antonios
postMONARCH, NCT05169567 / 2021-002301-10: Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer

Active, not recruiting
3
368
Europe, US, RoW
Abemaciclib, Fulvestrant, Placebo
Eli Lilly and Company, Eli Lilly and Company
Breast Neoplasm, Neoplasm Metastasis
02/24
02/26
IMPORTANT, NCT06044623: Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients

Recruiting
3
495
Europe
CDK 4/6 inhibitors, Endocrine therapy
Region Örebro County, University of Patras, University of Florence, Azienda USL Toscana Centro, Helsinki University Central Hospital, Institute for Medical Technology Assessment - the Netherlands, Security Labs Consulting Limited, Circular Economy Foundation, Universidad Nacional de Educación a Distancia, Hellenic Cooperative Oncology Group, University Hospital, Akershus, Uppsala County Council, Sweden, Hospital Clinic of Barcelona, Phaze Clinical Research & Pharma Consulting, Bröstcancerförbundet, Eunomia Ltd, University of Applied Sciences and Arts Northwestern Switzerland, CareAcross Ltd, Örebro University, Sweden
Metastatic Breast Cancer, Advanced Breast Cancer, Quality of Life, Toxicity, Older Patients
04/28
04/31
ASCAPE, NCT04879563: Artificial Intelligence Supporting CAncer Patients Across Europe - the Project

Active, not recruiting
2
500
Europe
ASCAPE-based follow-up strategy
Region Örebro County, UBITECH, ATOS, Siemens Corporation, Corporate Technology, Intrasoft, University of Patras, FORTH - Foundation for Research and Technology Hellas, Sphynx Technology Solutions AG, Faculty of Sciences, University of Novi Sad, Serbia, DFKI - German Research Center for Artificial Intelligence, CareAcross, National and Kapodistrian University of Athens, Greece, Fundacio Clinic Barcelona, Arthur's Legal, Fundacion iSYS
Breast Cancer, Prostate Cancer, Quality of Life, Survivorship, Toxicity
06/24
06/24
ARIADNE, NCT05900206: Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer

Recruiting
2
370
Europe
Trastuzumab deruxtecan, T-DXd, Enhertu, Docetaxel, Paclitaxel, Carboplatin, Trastuzumab, Herceptin, Pertuzumab, PErjeta, Ribociclib, Kisqali, Letrozole, Epirubicin, Cyclophosphamide
Karolinska University Hospital
Breast Cancer
04/27
04/32
Fadl, Helena
COPE, NCT04433364: - COVID-19 in Pregnancy and Early Childhood

Active, not recruiting
N/A
3834
Europe
biological samples, questionnaires and interviews
Sahlgrenska University Hospital, Sweden
Sars-CoV2, Covid-19, Pregnancy Complications, Pregnancy Preterm, Pregnancy in Diabetic, Neonatal Infection
12/26
12/40
Wickbom, Malin
NCT06453590: Treatment of Distal Malignant Biliary Obstruction by Uncovered, Partially Covered, or Fully Covered Metal Stents

Recruiting
N/A
450
Europe
Randomization to uncovered SEMS treating jaundice due to distal malignant biliary obstruction., Randomization to partially covered SEMS treating jaundice due to distal malignant biliary obstruction., Randomization to fully covered SEMS treating jaundice due to distal malignant biliary obstruction.
Region Stockholm
Pancreatic Cancer Non-resectable, Bile Duct Cancer, Papillary Carcinoma, Duodenal Cancer
01/25
01/26
Frey, Janusz
NCT04794777: Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer

Recruiting
3
450
Europe
Individualised therapy, Standard salvage therapy
Stefan Carlsson
Prostate Cancer
10/27
10/27
PCASTT, NCT02914873: SPCG17: Prostate Cancer Active Surveillance Trigger Trial

Recruiting
N/A
2000
Europe
Active surveillance
Uppsala University
Prostate Cancer
12/34
12/34
Sigmundsson, Gauti F
INTRAKS, NCT04536909: Indication and Treatment of Adult Kyphoscoliosis

Recruiting
N/A
300
Europe, Japan
Non-surgical, Surgical
University of Bergen, Oslo University Hospital, Kyoto University, Region Örebro County, Skane University Hospital, Haukeland University Hospital
Kyphoscoliosis
07/24
01/26
Sandström, Nadia
SWAG, NCT04592328: Sternal Wound and Aortic Graft (), an Observational Cohort Study.

Completed
N/A
50
Europe
Bacterial cultures taken during surgery.
Region Örebro County
Surgical Site Infection, Sternal Wound Infection
09/21
12/22
Forsström, Maria
NCT04613154: Magnesium as an Adjunct for Pain Treatment After Surgery for Thumb Base Arthrosis

Terminated
N/A
9
Europe
magnesiumcitrate, Placebo
Region Örebro County
Thumb Osteoarthritis
10/23
10/23
Hildén, Karin
IMPACT, NCT03831490: Study for Improving Maternal, Pregnancy and Child Outcomes

Completed
N/A
13000
Europe
history, mean material blod pressure, PlGF - blood sample, a- uterine doppler
Uppsala University, Thermo Fisher Scientific, Inc, Perkin Elmer Inc., Roche Pharma AG
Pre-Eclampsia
12/22
12/22
Jerlsström, Tomas
NCT04701151: NORTH-REG Dwell-Time Study

Active, not recruiting
4
314
Europe, RoW
Bacillus Calmette Guerin
Jørgen Bjerggaard Jensen, Aarhus University Hospital, Herlev Hospital, Odense University Hospital, Aalborg University Hospital, Regional Hospital West Jutland, Rigshospitalet, Denmark, Zealand University Hospital, Landspitali University Hospital, Sahlgrenska University Hospital, Sweden, Region Örebro County, Karolinska University Hospital
Side Effect of Drug
12/24
12/30
Kättström, Magdalena
IbruOnOff, NCT04771507: A Pilot Study on Intermittent Ibrutinib in Patients With Advanced-phase Chronic Lymphocytic Leukemia (CLL)

Recruiting
1/2
50
Europe
Ibrutinib, Imbruvica
Jeanette Lundin
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
04/23
12/27
Ohlsson-Nevo, Emma
NCT05028452: Feasibility of Internet Based Support (Carer eSupport) for Informal Caregivers of Patients With Head and Neck Cancer

Completed
N/A
32
Europe
Internet based support, Carer eSupport
Uppsala University, The Swedish Research Council, Swedish Cancer Society, Uppsala University Hospital, Region Västerbotten, Region Örebro County
Caregivers, Head and Neck Cancer, Feasibility Study
09/23
09/23
NCT04812652: Digitally Distributed Yoga for Women Treated for Breast Cancer

Active, not recruiting
N/A
229
Europe
Digitally distributed yoga, DigiYogaCaRe
Region Örebro County, The Swedish Breast Cancer Association, Uppsala-Örebro Regional Research Council
Breast Neoplasm Female
05/24
07/26
Rosdahl, Anja
CoVacc, NCT04920357: Immune Response to Vaccination Against Covid-19, a Follow up Study

Recruiting
N/A
3000
Europe
Vaccination
Umeå University, Region Västerbotten, Värmland County Council, Sweden, Örebro Läns Landsting, Sormland County Council, Sweden, Region Jämtland Härjedalen
Vaccination; Infection, Covid19
03/22
12/24
Joelson, Anders
SunBurst, NCT05003180: StUdy oN Burst Fractures

Recruiting
N/A
202
Europe
Surgical stabilization
Uppsala University, Sahlgrenska University Hospital, Sweden, Uppsala University Hospital, University Hospital, Umeå, University Hospital, Linkoeping, Skane University Hospital, Region Örebro County, Stockholm South General Hospital, Karolinska University Hospital, Oslo University Hospital, Haukeland University Hospital, Helse Stavanger HF, University Hospital, Akershus, Kalmar County Hospital, Ryhov County Hospital, Halmstad County Hospital, Centrallasarettet Västerås, St. Olavs Hospital, Karolinska Institutet
Thoracolumbar Burst Fracture
12/25
12/36
Ingberg, Edvin
NCT05048693: Use of New Antibiotics in Sweden

Completed
N/A
41
Europe
Uppsala University, Karolinska University Hospital, Sahlgrenska University Hospital, Sweden, University Hospital, Linkoeping, Skane University Hospital, University Hospital, Umeå, Örebro University, Sweden
Multi-antibiotic Resistance
12/23
12/23
Kaettstroem, Magdalena
CLL17, NCT04608318 / 2019-003854-99: Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL)

Active, not recruiting
3
897
Europe, RoW
Ibrutinib, Imbruvica, Venetoclax, ABT-199, Venclyxto, Obinutuzumab, GA101, Gazyvaro
German CLL Study Group, Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Nordic CLL Study Group (NCLLSG), Swiss Group for Clinical Cancer Research (SAKK), Cancer Trials Ireland, Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA), Grupo Español de Leucemia Linfocítica Crónica (GELLC), The Israeli CLL Study Group (ICLLSG)
Chronic Lymphoid Leukemia
03/27
03/27
Kattström, Magdalena
NCT03868722: Acalabrutinib and Venetoclax Treatment of Newly Diagnosed Patients With CLL at High Risk of Infection or Early Treatment

Recruiting
2/3
212
Europe
Acalabrutinib, Calquence, Venetoclax, Venclexta, Venclyxto
Rigshospitalet, Denmark, Stichting Hemato-Oncologie voor Volwassenen Nederland, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Karolinska Institutet
CLL
07/29
07/30
Kirrander, Peter
NCT05264337: Lymphedema After Urologic Surgery

Recruiting
N/A
400
Europe
Self-reported lymphedema, Dielectric constant ratio, Limb volume
Vastra Gotaland Region
Urinary Bladder Neoplasms, Prostatic Neoplasms, Testicular Neoplasms, Penile Cancer
01/27
01/30
Saber, Amanj
ILIT vs SLIT, NCT06061848: Intralymphatic Immunotherapy Enhanced by Vitamin-D, a Randomized Placebo-controlled Trial and Comparison With SLIT

Recruiting
2/3
360
Europe
SLIT Grazax ALK Nordic 75 000 SQ-T, ILIT + Vitamin D, Alutard SQ timothy and Vicotrat D3, ILIT + placebo, Alutard SQ timothy and Sodium chloride
Lars Olaf Cardell
Allergic Rhinitis Due to Grass Pollen
12/30
12/31
Hellkvist, Laila
ILIT vs SLIT, NCT06061848: Intralymphatic Immunotherapy Enhanced by Vitamin-D, a Randomized Placebo-controlled Trial and Comparison With SLIT

Recruiting
2/3
360
Europe
SLIT Grazax ALK Nordic 75 000 SQ-T, ILIT + Vitamin D, Alutard SQ timothy and Vicotrat D3, ILIT + placebo, Alutard SQ timothy and Sodium chloride
Lars Olaf Cardell
Allergic Rhinitis Due to Grass Pollen
12/30
12/31
Cajander, Sara
ELIMINATE, NCT06336317: Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsE

Recruiting
4
90
Europe
Influenza vaccine, Placebo
Region Örebro County, The Swedish Heart and Lung Association, Örebro University, Sweden, University of Cambridge
Acute Myocardial Infarction, Cardiovascular Diseases, Inflammatory Response
12/27
12/27
Hospital, Örebro U
NCT06342297: Dermatoscopy Guided Resection for Skin Cancer

Recruiting
N/A
400
Europe
Dermatoscopy
Region Örebro County
Basal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, Surgical Margin
12/25
01/26
 

Download Options